Blue Jet Healthcare [BLUEJET] vs Biocon [BIOCON] Detailed Stock Comparison

Blue Jet Healthcare
NSE
Loading...

Biocon
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Blue Jet Healthcare wins in 9 metrics, Biocon wins in 10 metrics, with 0 ties. Biocon appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Blue Jet Healthcare | Biocon | Better |
---|---|---|---|
P/E Ratio (TTM) | 37.48 | 112.34 | Blue Jet Healthcare |
Price-to-Book Ratio | 11.87 | 1.99 | Biocon |
Debt-to-Equity Ratio | 1.76 | 66.26 | Blue Jet Healthcare |
PEG Ratio | 0.27 | -1.18 | Biocon |
EV/EBITDA | 26.50 | 19.51 | Biocon |
Profit Margin (TTM) | 29.35% | 2.44% | Blue Jet Healthcare |
Operating Margin (TTM) | 32.50% | 7.46% | Blue Jet Healthcare |
EBITDA Margin (TTM) | 32.50% | 7.46% | Blue Jet Healthcare |
Return on Equity | 26.93% | 3.66% | Blue Jet Healthcare |
Return on Assets (TTM) | 21.53% | 1.72% | Blue Jet Healthcare |
Free Cash Flow (TTM) | $-341.15M | $17.18B | Biocon |
Dividend Yield | 0.11% | 0.26% | Biocon |
1-Year Return | 50.68% | 0.24% | Blue Jet Healthcare |
Price-to-Sales Ratio (TTM) | 11.02 | 3.04 | Biocon |
Enterprise Value | $131.52B | $629.36B | Biocon |
EV/Revenue Ratio | 10.76 | 3.99 | Biocon |
Gross Profit Margin (TTM) | 48.44% | 64.06% | Biocon |
Revenue per Share (TTM) | $70 | $131 | Biocon |
Earnings per Share (Diluted) | $20.70 | $3.20 | Blue Jet Healthcare |
Beta (Stock Volatility) | N/A | 0.23 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Blue Jet Healthcare vs Biocon Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Blue Jet Healthcare | -3.96% | -5.70% | -6.67% | -9.15% | -7.65% | 27.56% |
Biocon | -0.46% | -1.19% | -8.68% | 8.30% | 12.06% | -2.40% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Blue Jet Healthcare | 50.68% | 88.94% | 88.94% | 88.94% | 88.94% | 88.94% |
Biocon | 0.24% | 21.77% | -14.49% | 404.27% | 524.70% | 860.89% |
Performance & Financial Health Analysis: Blue Jet Healthcare vs Biocon
Metric | BLUEJET | BIOCON |
---|---|---|
Market Information | ||
Market Cap | ₹134.59B | ₹479.78B |
Market Cap Category | Mid cap | Large cap |
10 Day Avg. Volume | 356,828 | 3,029,441 |
90 Day Avg. Volume | 791,741 | 4,267,594 |
Last Close | ₹707.40 | ₹358.30 |
52 Week Range | ₹460.50 - ₹1,027.80 | ₹291.00 - ₹406.00 |
% from 52W High | -31.17% | -11.75% |
All-Time High | ₹1,027.80 (Jul 21, 2025) | ₹487.75 (Dec 21, 2020) |
% from All-Time High | -31.17% | -26.54% |
Growth Metrics | ||
Quarterly Revenue Growth | 1.18% | 0.15% |
Quarterly Earnings Growth | 1.41% | -0.95% |
Financial Health | ||
Profit Margin (TTM) | 0.29% | 0.02% |
Operating Margin (TTM) | 0.33% | 0.07% |
Return on Equity (TTM) | 0.27% | 0.04% |
Debt to Equity (MRQ) | 1.76 | 66.26 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹65.36 | ₹180.66 |
Cash per Share (MRQ) | ₹17.68 | ₹38.10 |
Operating Cash Flow (TTM) | ₹899.31M | ₹17.78B |
Levered Free Cash Flow (TTM) | ₹3.05B | ₹10.13B |
Dividends | ||
Last 12-Month Dividend Yield | 0.11% | 0.26% |
Last 12-Month Dividend | ₹1.00 | ₹1.00 |
Valuation & Enterprise Metrics Analysis: Blue Jet Healthcare vs Biocon
Metric | BLUEJET | BIOCON |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 37.48 | 112.34 |
Forward P/E | 47.48 | 36.24 |
PEG Ratio | 0.27 | -1.18 |
Price to Sales (TTM) | 11.02 | 3.04 |
Price to Book (MRQ) | 11.87 | 1.99 |
Market Capitalization | ||
Market Capitalization | ₹134.59B | ₹479.78B |
Enterprise Value | ₹131.52B | ₹629.36B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 10.76 | 3.99 |
Enterprise to EBITDA | 26.50 | 19.51 |
Risk & Other Metrics | ||
Beta | N/A | 0.23 |
Book Value per Share (MRQ) | ₹65.36 | ₹180.66 |
Financial Statements Comparison: Blue Jet Healthcare vs Biocon
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | BLUEJET | BIOCON |
---|---|---|
Revenue/Sales | ₹3.40B | ₹39.10B |
Cost of Goods Sold | ₹1.53B | ₹14.05B |
Gross Profit | ₹1.87B | ₹25.05B |
Research & Development | N/A | ₹-346.00M |
Operating Income (EBIT) | ₹1.35B | ₹2.94B |
EBITDA | ₹1.52B | ₹8.29B |
Pre-Tax Income | ₹1.47B | ₹969.00M |
Income Tax | ₹371.18M | ₹77.00M |
Net Income (Profit) | ₹1.10B | ₹892.00M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | BLUEJET | BIOCON |
---|---|---|
Cash & Equivalents | ₹329.79M | ₹32.27B |
Total Current Assets | ₹10.06B | ₹162.86B |
Total Current Liabilities | ₹2.56B | ₹143.34B |
Long-Term Debt | ₹165.26M | ₹129.45B |
Total Shareholders Equity | ₹11.33B | ₹277.13B |
Retained Earnings | N/A | ₹189.59B |
Property, Plant & Equipment | ₹3.00B | ₹4.32B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | BLUEJET | BIOCON |
---|---|---|
Operating Cash Flow | ₹539.01M | N/A |
Capital Expenditures | ₹-514.91M | N/A |
Free Cash Flow | ₹-54.59M | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | BLUEJET | BIOCON |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 356,828 | 3,029,441 |
Average Daily Volume (90 Day) | 791,741 | 4,267,594 |
Shares Outstanding | 173.47M | 1.20B |
Float Shares | 22.44M | 523.91M |
% Held by Insiders | 0.86% | 0.56% |
% Held by Institutions | 0.01% | 0.28% |
Dividend Analysis & Yield Comparison: Blue Jet Healthcare vs Biocon
Metric | BLUEJET | BIOCON |
---|---|---|
Last 12-Month Dividend | ₹1.00 | ₹1.00 |
Last 12-Month Dividend Yield | 0.11% | 0.26% |
3-Year Avg Annual Dividend | ₹0.33 | ₹1.33 |
3-Year Avg Dividend Yield | 0.19% | 0.36% |
3-Year Total Dividends | ₹1.00 | ₹4.00 |
Ex-Dividend Date | Sep 17, 2024 | Jul 04, 2025 |